Workplace NO and NO2 during combined treatment of infants with nasal CPAP and NO

Intensive Care Medicine

Volumn 32, Issue 12, 2006, Pages 2034-2041

  Lindwall, Robert ^a   Svensson, Mats E ^a   Frostell, Claes G ^b   Eksborg, Staffan ^b,c   Gustafsson, Lars E ^c  

^a DANDERYD HOSPITAL   (Sweden)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^c KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Chemiluminescence; CPAP; Inhaled nitric oxide; Intensive care; Nitrogen dioxide; Occupational exposure

Indexed keywords

NITRIC OXIDE; NITROGEN DIOXIDE; BRONCHODILATING AGENT;

AMBIENT AIR; ARTICLE; CHEMOLUMINESCENCE; HUMAN; INCUBATOR; INFANT; INHALATION; INTENSIVE CARE UNIT; NEWBORN INTENSIVE CARE; OCCUPATIONAL EXPOSURE; POSITIVE END EXPIRATORY PRESSURE; ROOM VENTILATION; SIMULATION; UNIVERSITY HOSPITAL; WORK ENVIRONMENT; WORKPLACE; AIR POLLUTANT; INHALATIONAL DRUG ADMINISTRATION; NEONATAL RESPIRATORY DISTRESS SYNDROME; NEWBORN; PHOTOCHEMICAL SMOG;

ADMINISTRATION, INHALATION; AIR POLLUTANTS, OCCUPATIONAL; BRONCHODILATOR AGENTS; CONTINUOUS POSITIVE AIRWAY PRESSURE; HUMANS; INFANT, NEWBORN; INTENSIVE CARE UNITS, NEONATAL; NITRIC OXIDE; NITROGEN DIOXIDE; OCCUPATIONAL EXPOSURE; OXIDANTS, PHOTOCHEMICAL; RESPIRATORY DISTRESS SYNDROME, NEWBORN;

EID: 33751516148     PISSN: 03424642     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00134-006-0393-1     Document Type: Article

References (30)

1. Stevens T, Blennow M, Soll R (2004) Early surfactant administration with brief ventilation vs selective surfactant and continued mechanical ventilation for preterm infants with or at risk for respiratory distress syndrome. Cochrane Database Syst Rev 3:CD003063
2. Soll RF, Morley CJ (2001) Prophylactic versus selective use of surfactant in preventing morbidity and mortality in preterm infants. Cochrane Database Syst Rev CD000510
3. Jonsson B, Katz-Salamon M, Faxelius G, Broberger U, Lagercrantz H (1997) Neonatal care of very-low-birthweight infants in special-care units and neonatal intensive-care units in Stockholm. Early nasal continuous positive airway pressure versus mechanical ventilation: gains and losses. Acta Paediatr Suppl 419:4-10
4. Verder H, Robertson B, Greisen G, Ebbesen F, Albertsen P, Lundstrom K, Jacobsen T (1994) Surfactant therapy and nasal continuous positive airway pressure for newborns with respiratory distress syndrome. Danish-Swedish Multicenter Study Group. N Engl J Med 331:1051-1055
5. Polin RA, Sahni R (2002) Newer experience with CPAP. Semin Neonatol 7:379-389
6. Van Marter LJ, Allred EN, Pagano M, Sanocka U, Parad R, Moore M, Susser M, Paneth N, Leviton A (2000) Do clinical markers of barotrauma and oxygen toxicity explain interhospital variation in rates of chronic lung disease? The Neonatology Committee for the Developmental Network. Pediatrics 105:1194-1201
7. Lindwall R, Frostell CG, Lonnqvist PA (2002) Delivery characteristics of a combined nitric oxide nasal continuous positive airway pressure system. Paediatr Anaesth 12:530-536
8. Lindwall R, Blennow M, Svensson M, Jonsson B, Berggren-Bostrom E, Flanby M, Lonnqvist PA, Frostell C, Norman M (2005) A pilot study of inhaled nitric oxide in preterm infants treated with nasal continuous positive airway pressure for respiratory distress syndrome. Intensive Care Med 31:959-964
9. Andrews P, Azoulay E, Antonelli M, Brochard L, Brun-Buisson C, Dobb G, Fagon JY, Gerlach H, Groeneveld J, Mancebo J, Metnitz P, Nava S, Pugin J, Pinsky M, Radermacher P, Richard C, Tasker R (2006) Year in review in intensive care medicine, 2005. III. Nutrition, pediatric and neonatal critical care, and experimental. Intensive Care Med 32:490-500
10. McCurnin DC, Pierce RA, Chang LY, Gibson LL, Osborne-Lawrence S, Yoder BA, Kerecman JD, Albertine KH, Winter VT, Coalson JJ, Crapo JD, Grubb PH, Shaul PW (2005) Inhaled NO improves early pulmonary function and modifies lung growth and elastin deposition in a baboon model of neonatal chronic lung disease. Am J Physiol Lung Cell Mol Physiol 288:L450-L459
11. Ballard PL, Gonzales LW, Godinez RI, Godinez MH, Savani RC, McCurnin DC, Gibson LL, Yoder BA, Kerecman JD, Grubb PH, Shaul PW (2006) Surfactant composition and function in a primate model of infant chronic lung disease: effects of inhaled nitric oxide. Pediatr Res 59:157-162
12. Jones C (1998) Inhaled nitric oxide: are the safety issues being addressed? Intensive Crit Care Nurs 14:271-275
13. Markhorst DG, Leenhoven T, Uiterwijk JW, Meulenbelt J, van Vught AJ (1996) Occupational exposure during nitric oxide inhalational therapy in a pediatric intensive care setting. Intensive Care Med 22:954-958
14. Putman E, van Golde LM, Haagsman HP (1997) Toxic oxidant species and their impact on the pulmonary surfactant system. Lung 175:75-103
15. Muller B, Seifart C, Barth PJ (1998) Effect of air pollutants on the pulmonary surfactant system. Eur J Clin Invest 28:762-777
16. Mourgeon E, Levesque E, Duveau C, Law-Koune JD, Charbit B, Ternissien E, Coriat P, Rouby JJ (1997) Factors influencing indoor concentrations of nitric oxide in a Parisian intensive care unit. Am J Respir Crit Care Med 156:1692-1695
17. Kinsella JP, Griebel J, Schmidt JM, Abman SH (2002) Use of inhaled nitric oxide during interhospital transport of newborns with hypoxemic respiratory failure. Pediatrics 109:158-161
18. Schedin U, Frostell CG, Gustafsson LE (1999) Formation of nitrogen dioxide from nitric oxide and their measurement in clinically relevant circumstances. Br J Anaesth 82:182-192
19. Moa G, Nilsson K, Zetterstrom H, Jonsson LO (1988) A new device for administration of nasal continuous positive airway pressure in the newborn: an experimental study. Crit Care Med 16:1238-1242
20. Merilainen PT (1990) A differential paramagnetic sensor for breath-by-breath oximetry. J Clin Monit 6:65-73
21. Phillips ML, Hall TA, Sekar K, Tomey JL (1999) Assessment of medical personnel exposure to nitrogen oxides during inhaled nitric oxide treatment of neonatal and pediatric patients. Pediatrics 104:1095-1100
22. Qureshi MA, Shah NJ, Hemmen CW, Thill MC, Kruse JA (2003) Exposure of intensive care unit nurses to nitric oxide and nitrogen dioxide during therapeutic use of inhaled nitric oxide in adults with acute respiratory distress syndrome. Am J Crit Care 12:147-153
23. Johansson C, Hadenius A, Johansson PÅ, Jonson T (1999) SHAPE, The Stockholm Study on Health Effects of Air Pollution and their Economic Consequences Part I: NO2 and Particulate Matter in Stockholm. 41:1-71
24. Benzing A, Loop T, Mols G, Geiger K (1999) Unintended inhalation of nitric oxide by contamination of compressed air: physiologic effects and interference with intended nitric oxide inhalation in acute lung injury. Anesthesiology 91:945-950
25. Lee KH, Tan PS, Rico P, Delgado E, Kellum JA, Pinsky MR (1997) Low levels of nitric oxide as contaminant in hospital compressed air: physiologic significance? Crit Care Med 25:1143-1146
26. Pinsky MR, Genc F, Lee KH, Delgado E (1997) Contamination of hospital compressed air with nitric oxide: unwitting replacement therapy. Chest 111:1759-1763
27. Tan PS, Genc F, Delgado E, Kellum JA, Pinsky MR (2002) Nitric oxide contamination of hospital compressed air improves gas exchange in patients with acute lung injury. Intensive Care Med 28:1064-1072
28. Berglund M, Boström CE, Bylin G, Ewetz L, Gustafsson LE, Moldeus P, Pershagen G, Victorin K (1993) Health risk evaluation of nitrogen oxides. Exposure. Scand J Work Environ Health 19 Suppl 2:1-72
29. Kraft M, Eikmann T, Kappos A, Kunzli N, Rapp R, Schneider K, Seitz H, Voss JU, Wichmann HE (2005) The German view: effects of nitrogen dioxide on human health - derivation of health-related short-term and long-term values. Int J Hyg Environ Health 208:305-318
30. Schedin U, Norman M, Gustafsson LE, Jonsson B, Frostell C (1997) Endogenous nitric oxide in the upper airways of premature and term infants. Acta Paediatr 86:1229-1235